William F Doyle
CIK 1194459 · View on SEC EDGAR ↗
First SEC filing: July 13, 2022 · Latest: July 13, 2022
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | NVCR | S | 21,330 | $13.43 | $286,462 | 328,397 Direct | -6.10% | Disposed | 35.4% (price as of 2026-08-20) |
| March 3, 2026 | NVCR | S | 50,557 | $12.79 | $646,624 | 349,727 Direct | -12.63% | Disposed | 42.1% (price as of 2026-08-20) |
| May 21, 2024 | ELAN | P | 15,000 | $16.98 | $254,700 | 76,330 Direct | +24.46% | Acquired | 42.6% (price as of 2026-08-20) |
| March 8, 2024 | ELAN | P | 15,000 | $16.30 | $244,500 | 61,330 Direct | +32.38% | Acquired | 48.6% (price as of 2026-08-20) |
| June 27, 2019 | NERV | P | 3,500 | $5.50 | $19,250 | 26,111 Direct | +15.48% | Acquired | -89.2% (price as of 2026-08-20) |
| May 30, 2019 | NVCR | S | 48,100 | $53.07 | $2,552,667 | 846,463 Direct | -5.38% | Disposed | -65.7% (price as of 2026-08-20) |
| May 29, 2019 | NVCR | S | 1,900 | $53.10 | $100,890 | 894,563 Direct | -0.21% | Disposed | -65.8% (price as of 2026-08-20) |
| May 9, 2019 | NVCR | S | 31,460 | $47.37 | $1,490,260 | 896,463 Direct | -3.39% | Disposed | -61.6% (price as of 2026-08-20) |
| May 8, 2019 | NVCR | S | 32,218 | $47.52 | $1,530,999 | 869,155 Direct | -3.57% | Disposed | -61.7% (price as of 2026-08-20) |
| May 7, 2019 | NVCR | S | 32,098 | $47.67 | $1,530,112 | 842,605 Direct | -3.67% | Disposed | -61.9% (price as of 2026-08-20) |
| May 6, 2019 | NVCR | S | 29,038 | $48.07 | $1,395,857 | 815,935 Direct | -3.44% | Disposed | -62.2% (price as of 2026-08-20) |
| May 3, 2019 | NVCR | S | 29,966 | $45.21 | $1,354,763 | 786,205 Direct | -3.67% | Disposed | -59.8% (price as of 2026-08-20) |
| Feb. 28, 2019 | NVCR | S | 3,097 | $53.68 | $166,247 | 918,306 Direct | -0.34% | Disposed | -66.1% (price as of 2026-08-20) |
| Dec. 20, 2018 | NERV | P | 2,000 | $6.50 | $13,000 | 22,611 Direct | +9.70% | Acquired | -90.8% (price as of 2026-08-20) |
| Dec. 11, 2018 | NERV | P | 4,000 | $7.95 | $31,800 | 20,611 Direct | +24.08% | Acquired | -92.5% (price as of 2026-08-20) |
| Dec. 10, 2018 | NERV | P | 2,000 | $8.00 | $16,000 | 16,611 Direct | +13.69% | Acquired | -92.6% (price as of 2026-08-20) |
| Nov. 20, 2018 | NERV | P | 2,000 | $8.20 | $16,400 | 14,611 Direct | +15.86% | Acquired | -92.7% (price as of 2026-08-20) |
| Oct. 11, 2018 | NERV | P | 600 | $10.00 | $6,000 | 12,611 Direct | +5.00% | Acquired | -94.0% (price as of 2026-08-20) |
| Sept. 17, 2018 | NERV | P | 1,800 | $10.50 | $18,900 | 12,011 Direct | +17.63% | Acquired | -94.3% (price as of 2026-08-20) |
| Sept. 14, 2018 | NERV | P | 200 | $10.50 | $2,100 | 10,211 Direct | +2.00% | Acquired | -94.3% (price as of 2026-08-20) |
| Sept. 13, 2018 | NERV | P | 2,000 | $10.50 | $21,000 | 10,011 Direct | +24.97% | Acquired | -94.3% (price as of 2026-08-20) |
| Sept. 11, 2018 | NERV | P | 4,011 | $9.72 | $38,987 | 8,011 Direct | +100.28% | Acquired | -93.9% (price as of 2026-08-20) |
| Sept. 10, 2018 | NERV | P | 4,000 | $9.88 | $39,520 | 4,000 Direct | — | Acquired | -94.0% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 28, 2026 | PROK | Director stock option (right to buy) | Class A Common Stock (135,000) | $1.81 | May 28, 2036 | 135,000 | Acquired |
| March 3, 2026 | NVCR | Stock Option (Right to Buy) | Ordinary Shares (30,072) | $13.30 | March 3, 2036 | 30,072 | Acquired |
| March 3, 2026 | NVCR | Stock Option (Right to Buy) | Ordinary Shares (258,445) | $13.30 | March 3, 2036 | 258,445 | Acquired |
| May 29, 2025 | PROK | Director stock option (right to buy) | Class A Ordinary Shares (125,862) | $0.72 | May 29, 2035 | 125,862 | Acquired |
| May 30, 2024 | PROK | Director stock option (right to buy) | Class A Ordinary Shares (62,558) | $4.20 | May 30, 2034 | 62,558 | Acquired |
| June 29, 2023 | PROK | Director Stock Option (right to buy) | Class A Ordinary Shares (48,128) | $10.56 | June 29, 2033 | 48,128 | Acquired |
| July 11, 2022 | PROK | Common Units in ProKidney LP [F3] | Class A Ordinary Shares (1,514,326) | — | — | 1,514,326 | Acquired |
| July 11, 2022 | PROK | Class B Ordinary Shares | Class A Ordinary Shares (1,514,326) | — | — | 1,514,326 | Acquired |
| June 10, 2022 | NERV | Stock Option (right to buy) [F1] | Common Stock | — | June 9, 2032 | 2,500 | Acquired |
| June 11, 2021 | NERV | Stock Option (right to buy) [F1] | Common Stock (40,000) | $2.90 | June 10, 2031 | 40,000 | Acquired |
| June 11, 2020 | NERV | Stock Option (right to buy) [F1] | Common Stock (40,000) | $3.40 | June 10, 2030 | 40,000 | Acquired |
| July 30, 2019 | NVCR | Options to Buy Ordinary Shares [F1] | Ordinary Shares (10,412) | $83.30 | July 30, 2029 | 10,412 | Acquired |
| June 12, 2019 | NERV | Stock option (right to buy) | Common Stock (20,000) | $4.50 | June 11, 2029 | 20,000 | Acquired |
| May 31, 2019 | NERV | Stock Option (right to buy) | Common Stock (20,000) | $5.21 | May 30, 2029 | 20,000 | Acquired |
| May 8, 2019 | NVCR | Options to Buy Ordinary Shares | Ordinary Shares (35,000) | $47.56 | May 8, 2029 | 35,000 | Acquired |
| May 8, 2019 | NVCR | Options to Buy Ordinary Shares | Ordinary Shares (115,060) | $47.56 | May 8, 2029 | 115,060 | Acquired |
| May 8, 2019 | NVCR | Restricted Stock Units | Ordinary Shares (58,768) | $0.00 | — | 58,768 | Disposed |
| May 7, 2019 | NVCR | Restricted Stock Units | Ordinary Shares (58,768) | $0.00 | — | 58,768 | Disposed |
| May 6, 2019 | NVCR | Restricted Stock Units | Ordinary Shares (58,768) | $0.00 | — | 58,768 | Disposed |
| May 3, 2019 | NVCR | Restricted Stock Units | Ordinary Shares (58,768) | $0.00 | — | 58,768 | Disposed |
| May 2, 2019 | NVCR | Restricted Stock Units | Ordinary Shares (58,768) | $0.00 | — | 58,768 | Disposed |
| March 22, 2019 | NVCR | Options to Buy Ordinary Shares | Ordinary Shares (44,953) | $47.04 | March 21, 2029 | 44,953 | Acquired |
| Feb. 27, 2019 | NVCR | Restricted Stock Units | Ordinary Shares (9,260) | $0.00 | — | 9,260 | Disposed |
| Aug. 1, 2018 | NERV | Stock Option (Right to Buy) | Common Stock (20,000) | $7.95 | Aug. 1, 2028 | 20,000 | Acquired |
| July 16, 2018 | NVCR | Warrants | Ordinary Shares (2,330) | $3.59 | July 21, 2018 | 2,330 | Disposed |
| June 7, 2018 | NERV | Stock Option (Right to Buy) | Common Stock (20,000) | $8.25 | June 6, 2028 | 20,000 | Acquired |
| May 2, 2018 | NVCR | Restricted Stock Units | Ordinary Shares (881,519) | — | — | 293,840 | Disposed |
| Feb. 27, 2018 | NVCR | Restricted Stock Unit | Ordinary Shares (27,778) | — | — | 27,778 | Acquired |
| Feb. 27, 2018 | NVCR | Options to Buy Ordinary Shares | Ordinary Shares (202,758) | $21.15 | Feb. 27, 2028 | 202,758 | Acquired |
| Jan. 22, 2018 | NVCR | Warrants | Ordinary Shares (1,549) | $3.59 | Jan. 22, 2018 | 1,549 | Disposed |
| Dec. 10, 2017 | NERV | Option Grant (Right to Buy) | Common Stock (40,000) | $5.70 | Dec. 10, 2027 | 40,000 | Acquired |
| June 14, 2017 | NVCR | Warrants | Ordinary Shares (6,498) | $3.59 | July 31, 2017 | 6,498 | Disposed |
| May 2, 2017 | NVCR | Restricted Stock Unit | Ordinary shares (881,519) | — | — | 881,519 | Acquired |
| May 2, 2017 | NVCR | Options to Buy Ordinary Shares | Ordinary shares (881,519) | $11.85 | May 2, 2027 | 881,519 | Acquired |
| May 2, 2017 | NVCR | Options to Buy Ordinary Shares | Ordinary shares (881,519) | $11.85 | May 2, 2027 | 881,519 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $750,000 | — | $587,505 | $2,359,400 | $843,750 | — | $18,000 | $4,558,655 |
| 2017 | $750,000 | — | $10,446,000 | $11,750,648 | $810,000 | — | $18,000 | $23,774,648 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.